SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-08-018004
Filing Date
2008-03-17
Accepted
2008-03-17 16:32:57
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a08-2579_110k.htm 10-K 1663774
2 EX-10.58 a08-2579_1ex10d58.htm EX-10.58 137614
3 EX-10.59 a08-2579_1ex10d59.htm EX-10.59 107509
4 EX-10.60 a08-2579_1ex10d60.htm EX-10.60 88056
5 EX-10.61 a08-2579_1ex10d61.htm EX-10.61 109516
6 EX-10.62 a08-2579_1ex10d62.htm EX-10.62 4016
7 EX-23 a08-2579_1ex23.htm EX-23 4636
8 EX-31.1 a08-2579_1ex31d1.htm EX-31.1 12643
9 EX-31.2 a08-2579_1ex31d2.htm EX-31.2 12571
10 EX-32 a08-2579_1ex32.htm EX-32 9476
11 GRAPHIC g25791ki01i001.jpg GRAPHIC 2526
12 GRAPHIC g25791bgi001.gif GRAPHIC 3816
  Complete submission text file 0001104659-08-018004.txt   2160357
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 08693292
SIC: 2834 Pharmaceutical Preparations